Robuta

https://adisinsight.springer.com/drugsafety/803637617?error=cookies_not_supported&code=1c65511e-6fe1-4903-ae92-f1bf362fe9f8 Imatinib - AdisInsight A man in his 20s [exact age at reaction onset not stated] developed myelotoxicity during treatment with imatinib for dermatofibrosarcoma protuberans.The man was imatinibadisinsight https://data.mendeley.com/datasets/ft27d96y63/1 CX-5461 potentiates imatinib-induced apoptosis in K562 cells by stimulating KIF1B expression (Part... The selective RNA polymerase I inhibitor CX-5461 has been shown to be effective in treating some types of leukemic disorders. Emerging evidence suggests that... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-imatinib-after-surgery-for-gastrointestinal-stromal-tumour-eortc-62024 A trial looking at imatinib after surgery for gastrointestinal stromal tumours (EORTC 62024) This trial was trying to find out if drug called imatinib (Glivec) could stop or delay a gastrointestinal stromal tumour (GIST) coming back after surgery. https://transportal.compbio.ucsf.edu/compounds/imatinib/ Imatinib Transporter information for Imatinib. imatinib https://www.wikidata.org/wiki/Q35628978 The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid... scientific article published on 24 October 2006 imatinib mesylate https://www.news-medical.net/news/20121102/Imatinib-mesylate-effectively-treats-children-with-neurofibromatosis-type-1-tumors.aspx Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumors Jun 19, 2019 - Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially... imatinib mesylateeffectivelytreatschildrenneurofibromatosis https://www.wikidata.org/wiki/Q37692798 Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at... scientific article published on September 2009 https://researchportal.helsinki.fi/sv/publications/short-and-long-term-effects-of-imatinib-in-hospitalized-covid-19-/ Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial -... https://adisinsight.springer.com/drugsafety/801135897?error=cookies_not_supported&code=2f333bd9-6fda-4c87-8f31-323f822e0600 Imatinib - AdisInsight A 76-year-old man developed multiple myeloma (MM) after receiving imatinib for chronic myeloid leukaemia; he subsequently died.After his diagnosis, the man was imatinibadisinsight https://pubmed.ncbi.nlm.nih.gov/22772433/ Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in... Disease progression after treatment with a particular therapy, in the traditional view of cancer chemotherapy, indicates resistance to that treatment. However,... in thetyrosine kinaseunderstandingresistance https://adisinsight.springer.com/drugsafety/803879542?error=cookies_not_supported&code=46ee218f-1c1e-48e0-867a-0970efd6f13e Imatinib - AdisInsight In a study involving 123 patients conducted between July 2002 and August 2013, a patient [age and sex not stated] was described, who exhibited lack of efficacy imatinibadisinsight https://pubmed.ncbi.nlm.nih.gov/34052176/ Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia:... Upfront imatinib was generally well tolerated among elderly Turkish patients with CML with non-inferior responses and long-term outcomes when compared with... efficacy and safety https://adisinsight.springer.com/drugsafety/803832406?error=cookies_not_supported&code=05e0ce5f-8f38-4275-b1a9-fa0b098f9d23 Imatinib - AdisInsight A 41-year-old woman developed intolerable gastrointestinal adverse reactions during the treatment with imatinib for gastrointestinal stromal tumor.The woman was imatinibadisinsight https://adisinsight.springer.com/drugsafety/803923343?error=cookies_not_supported&code=791f5016-0fb7-4c24-bf27-6a6785c88b7d Imatinib - AdisInsight A patient with chronic myeloid leukaemia developed undifferentiated blast crisis while receiving imatinib. imatinibadisinsight https://www.scirp.org/journal/PaperInformation?PaperID=44502 Regional Evaluation of Tolerability and Efficacy of Imatinib Mesylate in Patients with Chronic... Sixty patients with Chronic Myeloid Leukemia (CML) who were on oral imatinib were included in this study. The study aimed to evaluate patients characteristic,... https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/82009-0086/ 82009-0086 Imatinib Mesylate - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. imatinib mesylatendc https://vivo.colorado.edu/display/meshid_D02.241.223.100.100.435 Acids, Carbocyclic - Imatinib Mesylate | CU Experts | CU Boulder imatinib mesylateacidscuexpertsboulder https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/72485-0202/ 72485-0202 Imatinib mesylate - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. imatinib mesylatendc https://www.wikidata.org/wiki/Q58179557 Survival advantage from imatinib compared with the combination interferon- plus cytarabine in... scientific article published on 20 April 2006 https://pubmed.ncbi.nlm.nih.gov/18029844/ CT and PET: early prognostic indicators of response to imatinib mesylate in patients with... The two best metrics were the optimized PET SUVmax threshold of 3.4 at 1 month (p = 0.00002) and the optimized CT bidimensional measurement threshold (no... https://researchconnect.buffalo.edu/en/publications/induction-of-imatinib-metabolism-by-hypericum-perforatum-3/ Induction of imatinib metabolism by hypericum perforatum [3] - SUNY University at Buffalo hypericum perforatum https://adisinsight.springer.com/drugsafety/803811727?error=cookies_not_supported&code=21fc948e-c5b3-454b-b0ae-058d5e9f9d15 Dasatinib/eltrombopag/imatinib - AdisInsight A 56-year-old woman developed thrombocytopenia during treatment with dasatinib and imatinib for chronic-phase chronic myeloid leukemia (CP-CML). Additionally, dasatinibeltrombopagimatinibadisinsight https://portal.fis.tum.de/en/publications/secondary-malignancies-in-chronic-myeloid-leukemia-patients-after-2/ Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment:... chronic myeloid leukemiasecondary malignancies https://pubmed.ncbi.nlm.nih.gov/23127201/ Monitoring and switching patterns of patients with chronic myeloid leukemia treated with imatinib... Based on the guidelines, the rates of treatment monitoring and switching upon failure were low, demonstrating the need for improvement in CML care in community... chronic myeloid leukemia https://www.nice.org.uk/guidance/ta86/chapter/5-Recommendations-for-further-research 5 Recommendations for further research | Imatinib for the treatment of unresectable and/or... Evidence-based recommendations on imatinib for treating unresectable or metastatic gastrointestinal stromal tumours in adults further research https://portal.research.lu.se/sv/publications/role-of-znf224-in-c-myc-repression-and-imatinib-responsiveness-in/fingerprints/ Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia -... https://id.wikibooks.org/wiki/Istimewa:Pranala_balik/Informasi_Obat/Imatinib_mesilat Halaman yang memiliki pranala ke "Informasi Obat/Imatinib mesilat" - Wikibuku bahasa Indonesia informasi obat https://ocw.mit.edu/courses/7-88j-protein-folding-and-human-disease-spring-2015/external-resources/bcr-abl-point-mutants-isolated-from-patients-with-imatinib-mesylate-resistant-chronic-mye51a1b63a-a762-4490-b23b-fc41f6c67889/ BCR-ABL Point Mutants Isolated from Patients with Imatinib Mesylate-resistant Chronic Myeloid... MIT OpenCourseWare is a web based publication of virtually all MIT course content. OCW is open and available to the world and is a permanent MIT activity https://pubmed.ncbi.nlm.nih.gov/20007927/ Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results In a randomized, placebo-controlled trial of patients with mild to moderate IPF followed for 96 weeks, imatinib did not affect survival or lung function.... idiopathic pulmonary fibrosisplacebo controlled trialtreatment forimatinib https://pmc.ncbi.nlm.nih.gov/articles/PMC5697457/ Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx... Imatinib mesylate is approved for the treatment of Chronic Myeloid Leukemia (CML). About 20% of patients with CML do not respond to treatment with Imatinib... https://kclpure.kcl.ac.uk/portal/en/publications/imatinib-optimized-therapy-improves-major-molecular-response-rate/ Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid... https://pubmed.ncbi.nlm.nih.gov/39745285/ Efficacy and Safety of Treating Pulmonary Arterial Hypertension With Imatinib: A Meta-Analysis of... Pulmonary vascular remodeling and arterial hypertension (PAH) correlate with increased platelet-derived growth factor activity and elevated KIT expression.... efficacy and safety https://eprints.ncl.ac.uk/151017 Outcomes by cytogenetic and molecular response at 12 and 18 months of imatinib in patients with... https://pubmed.ncbi.nlm.nih.gov/35015587/ Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny Labeling Generic versions of imatinib were dispensed frequently for indications both included (CML) and excluded (GIST) from the skinny labeling, although patients with... the impactindicationspecificgenericuptake https://adisinsight.springer.com/drugsafety/803112195?error=cookies_not_supported&code=f368d449-0e9b-416d-954a-a0b4f7c4a409 Imatinib - AdisInsight A 46-year-old woman developed acute liver failure while receiving imatinib.The woman had a history of a pelvic gastrointestinal stromal tumour. She started imatinibadisinsight https://cureresearch4type1diabetes.blogspot.com/2014/03/imatinib-gleevec-glivec-finally-starts.html Current Research into Cures for Type-1 Diabetes: Imatinib ("Gleevec" / "Glivec") Finally Starts a... A year ago, researchers (Drs. Gitelman and Bluestone) at UCSF filed the paperwork to start a clinical trial testing Gleevec on people. Now,... https://experts.umn.edu/en/publications/response-monitoring-tolerability-and-effectiveness-of-imatinib-tr/ Response monitoring, tolerability, and effectiveness of imatinib treatment for chronic myeloid... treatment forresponsemonitoringtolerabilityeffectiveness https://pediatrics.ucsf.edu/node/324146 The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and... https://forsaljningavaktieryzqu.web.app/71065/3864.html Imatinib and gastrointestinal stromal tumors: Where do we go imatinibgastrointestinaltumorsgo https://pubs.rsc.org/en/content/articlelanding/2021/AN/D0AN01860K An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with... The anticancer drug imatinib is often involved in therapeutic drug monitoring (TDM) studies aimed at improving the treatment of several forms of leukemia and... therapeutic drug monitoring https://pubmed.ncbi.nlm.nih.gov/41225551/ Cytogenetic profile of chronic myeloid leukaemia patients resistant to imatinib at tertiary level... Cytogenetic anomalies such as trisomy 8, trisomy 19, and complex karyotypes may contribute to TKI resistance. Further study is needed to understand additional... chronic myeloid leukaemia https://pubmed.ncbi.nlm.nih.gov/24456693/ BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian... Discovery of imatinib mesylate (IM) as the targeted BCR-ABL protein tyrosine kinase inhibitor (TKI) has resulted in its use as the frontline therapy for... abl kinase https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090795 Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour... Osteosarcoma is the most common primary malignant bone tumour characterized by osteoid production and/or osteolytic lesions of bone. A lack of response to... https://pubmed.ncbi.nlm.nih.gov/17200352/ Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal... The histologic response to imatinib is heterogeneous and does not correlate well with clinical response. Second-site KIT mutations are rare in... pathologicmolecularheterogeneityimatinibstable https://infoscience.epfl.ch/entities/publication/a1451316-e342-4d9c-8da6-e69c139ce282 Medical Guidelines Reconciling Medical Software and Electronic Devices: Imatinib Case-study Nowadays medical software is tightly coupled with medical devices that perform patient state monitoring and lately even some basic treatment procedures.... medical guidelineselectronic devicesreconcilingsoftwareimatinib https://pmc.ncbi.nlm.nih.gov/articles/PMC3010822/ Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in... Imatinib mesylate (IM), an original Abl tyrosine kinase inhibitor, entered the clinics in 1998 for the treatment of patients with chronic myeloid leukemia... https://cordis.europa.eu/project/id/101005142/es Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory... The accumulation of fluid in the lungs is a significant feature of the pathology in patients with severe Covid-19 infection. This build up of fluid,... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-imatinib-for-children-and-young-people-with-acute-lymphoblastic-leukaemia A trial looking at imatinib (Glivec) for children and young people with acute lymphoblastic... This trial looked at imatinib (Glivec) for children and young people with Philadelphia positive acute lymphoblastic leukaemia (ALL). for children and young people https://eprints.ncl.ac.uk/85930 Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative... https://www.wikidata.org/wiki/Q80200756 Isodicentric Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant patients - Wikidata scientific article published on 01 April 2007 imatinib mesylatephiladelphiachromosomesgleevecresistant https://arup.utah.edu/media/shortTopics/spot_mcmillin_imatinib_2017/videoLecture.php Educational Resources - Spotlight on Testing: Imatinib - Therapeutic Drug Monitoring educational resourcesspotlighttestingimatinibtherapeutic https://adisinsight.springer.com/drugsafety/803883940?error=cookies_not_supported&code=5e1ad03c-b2a9-44ea-9b39-4e24cc98072f Dasatinib/imatinib/prednisolone - AdisInsight A 60-year-old woman developed Epstein-Barr virus (EBV) associated lymphoproliferative disorder (LPD) during treatment with dasatinib and prednisolone for dasatinibimatinibprednisoloneadisinsight https://www.mdpi.com/2072-6694/15/1/143 Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib... c-KIT is a promising therapeutic target against gastrointestinal stromal tumor (GIST). In order to identify novel c-KIT inhibitors capable of overcoming... https://adisinsight.springer.com/trials/700241810?error=cookies_not_supported&code=e62a009d-81fc-48e2-8ea9-639b730a2b68 Pilot study: Imatinib for the treatment of plexiform neurofibromas in NF1 patients. [Studio pilota... This study is investigating the efficacy and safety of imatinib in patients with neurofibromatoses (NF1) and plexiform neurofibromas. The primary endpoint is https://adisinsight.springer.com/drugsafety/801026847?error=cookies_not_supported&code=03d51424-32a1-4a8f-b4ea-6c74b8b412d8 Imatinib/sunitinib - AdisInsight A 73-year-old woman developed hypothyroidism while receiving imatinib, then sunitinib, for metastatic gastrointestinal stromal cancer.The woman was receiving imatinibsunitinibadisinsight https://www.cancerresearchuk.org/about-cancer/treatment/drugs/imatinib Imatinib (Glivec) | Cancer drugs | Cancer Research UK Imatinib (Glivec) is a targeted cancer drug. It as a treatment for several types of cancer. Find out how you have it and possible side effects. cancer drugsimatinibglivecresearchuk https://publikationen.uni-tuebingen.de/xmlui/handle/10900/55307 Cellular Uptake of Imatinib into Leukemic Cells Is Independent of Human Organic Cation Transporter... https://pmc.ncbi.nlm.nih.gov/articles/PMC6440723/ Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected... This phase 2, multi-institutional clinical trial assesses whether patients with resected primary gastrointestinal stromal tumor receiving 5 years of adjuvant...